关注
Mohammed Alhusayan
Mohammed Alhusayan
University of Pennsylvania
在 pennmedicine.upenn.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Loss of LCMT1 and biased protein phosphatase 2A heterotrimerization drive prostate cancer progression and therapy resistance
R Rasool, CM O’Connor, CK Das, M Alhusayan, BK Verma, S Islam, ...
Nature Communications 14 (1), 5253, 2023
92023
Unraveling Verapamil’s Multidimensional Role in Diabetes Therapy: From β-Cell Regeneration to Cholecystokinin Induction in Zebrafish and MIN6 Cell-Line Models
H Arefanian, A Al Madhoun, F Al-Rashed, F Alzaid, F Bahman, R Nizam, ...
Cells 13 (11), 949, 2024
2024
NSD2 is a requisite subunit of the AR/FOXA1 neo-enhanceosome in promoting prostate tumorigenesis
A Parolia, S Eyunni, BK Verma, E Young, L Liu, J George, S Aras, CK Das, ...
bioRxiv, 2024
2024
Abstract A055: NSD2 is a requisite and targetable subunit of the AR/FOXA1 neo-enhanceosome complex in prostate cancer cells
A Parolia, BK Verma, S Eyunni, S Aras, SE Carson, E Young, CK Das, ...
Cancer Research 83 (11_Supplement), A055-A055, 2023
2023
系统目前无法执行此操作，请稍后再试。
文章 1–4
共建清朗的网络空间,如遇有害信息,请举报。
本站数据皆整合自互联网公开资源索引,方便科研学术方面查询,并不存储相关数据资源;如对此有异议,请联系我们解决.
© 2023 学术资源搜索   @联系我们 | 申请短期会员 | 数据源提交